308 related articles for article (PubMed ID: 12580046)
1. [The application of antisense technology in ophthalmology].
Guo Y; Ge J
Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
[TBL] [Abstract][Full Text] [Related]
2. Antisense-mediated redirection of mRNA splicing.
Vacek M; Sazani P; Kole R
Cell Mol Life Sci; 2003 May; 60(5):825-33. PubMed ID: 12827272
[TBL] [Abstract][Full Text] [Related]
3. Antisense technology for cancer therapy: does it make sense?
Carter G; Lemoine NR
Br J Cancer; 1993 May; 67(5):869-76. PubMed ID: 8494718
[No Abstract] [Full Text] [Related]
4. Antisense strategies for the control of aberrant gene expression.
Sczakiel G
J Hematother; 1994; 3(4):305-13. PubMed ID: 7735826
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
6. Making sense of antisense.
Murakami A
Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
[No Abstract] [Full Text] [Related]
7. Antisense strategies: functions and applications in immunology.
Varga LV; Tóth S; Novák I; Falus A
Immunol Lett; 1999 Aug; 69(2):217-24. PubMed ID: 10482355
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of oncogene expression in vitro and in vivo by antisense oligonucleotides.
Neckers L; Rosolen A; Fahmy B; Whitesell L
Ann N Y Acad Sci; 1992 Oct; 660():37-44. PubMed ID: 1340154
[No Abstract] [Full Text] [Related]
9. Antisense and sensibility.
Dove A
Nat Biotechnol; 2002 Feb; 20(2):121-4. PubMed ID: 11821852
[No Abstract] [Full Text] [Related]
10. Antisense DNA and RNA agents against picornaviruses.
Lim T; Yuan J; Zhang HM; Sall A; Liu Z; Su Y; Yang D
Front Biosci; 2008 May; 13():4707-25. PubMed ID: 18508540
[TBL] [Abstract][Full Text] [Related]
11. Antisense inhibition of oncogene expression.
Neckers L; Whitesell L; Rosolen A; Geselowitz DA
Crit Rev Oncog; 1992; 3(1-2):175-231. PubMed ID: 1312868
[TBL] [Abstract][Full Text] [Related]
12. Antisense tumor therapy (a dream under construction).
Kopper L; Kovalszky I
In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725
[TBL] [Abstract][Full Text] [Related]
13. [Antisense gene therapy and its application in ophthalmology].
Sun J; Xie LX
Zhonghua Yan Ke Za Zhi; 2005 Jan; 41(1):87-90. PubMed ID: 15774131
[No Abstract] [Full Text] [Related]
14. The therapeutic potential of antisense oligonucleotides.
Sharma HW; Narayanan R
Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
[TBL] [Abstract][Full Text] [Related]
15. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
Branch AD
Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
[TBL] [Abstract][Full Text] [Related]
16. RNA therapeutics in ophthalmology - translation to clinical trials.
Gupta A; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
Exp Eye Res; 2021 Apr; 205():108482. PubMed ID: 33548256
[TBL] [Abstract][Full Text] [Related]
17. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
DeMoor JM; Vincent MD; Collins OM; Koropatnick J
Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
[TBL] [Abstract][Full Text] [Related]
18. [Antisense oligonucleotides: a new therapeutic approach].
Guinot P; Temsamani J
Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
[TBL] [Abstract][Full Text] [Related]
19. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Sommer W; Heilig M
Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic applications of antisense oligonucleotides in asthma and allergy.
Isidoro-García M; Dávila I
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
